Structural biology of the GAD autoantigen

Autoimmunity Reviews

Volumn 9, Issue 3, 2010, Pages 148-152

  Fenalti, Gustavo ^a   Buckle, Ashley M ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Antibody antigen interactions; Antigenicity; Autoantigen; Autoepitope; Glutamic acid decarboxylase; Type 1 diabetes

Indexed keywords

GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIGENICITY; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CRYSTAL STRUCTURE; EPITOPE MAPPING; HUMAN; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

ANIMALS; AUTOANTIGENS; EPITOPES; GLUTAMATE DECARBOXYLASE; HUMANS; ISOENZYMES; STRUCTURAL HOMOLOGY, PROTEIN;

EID: 72149133903     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.05.003     Document Type: Review

References (39)

1. Battaglioli G., Liu H., and Martin D.L. Kinetic differences between the isoforms of glutamate decarboxylase: implications for the regulation of GABA synthesis. J Neurochem 86 (2003) 879-887
2. Fenalti G., Law R.H., Buckle A.M., Langendorf C., Tuck K., Rosado C.J., et al. GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop. Nat Struct Mol Biol 14 (2007) 280-286
3. Kash S.F., Johnson R.S., Tecott L.H., Noebels J.L., Mayfield R.D., Hanahan D., et al. Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci U S A 94 (1997) 14060-14065
4. Kash S.F., Tecott L.H., Hodge C., and Baekkeskov S. Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci U S A 96 (1999) 1698-1703
5. Solimena M., Folli F., Aparisi R., Pozza G., and De Camilli P. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. New Engl J Med 322 (1990) 1555-1560
6. Solimena M., Folli F., Denis-Donini S., Comi G.C., Pozza G., De Camilli P., et al. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. New Engl J Med 318 (1988) 1012-1020
7. Ramirez-Montealegre D., Chattopadhyay S., Curran T.M., Wasserfall C., Pritchard L., Schatz D., et al. Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Neurology 64 (2005) 743-745
8. Honnorat J., Saiz A., Giometto B., Vincent A., Brieva L., de Andres C., et al. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch neurol 58 (2001) 225-230
9. Peltola J., Kulmala P., Isojarvi J., Saiz A., Latvala K., Palmio J., et al. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 55 (2000) 46-50
10. Baekkeskov S. Immunoreactivity to a 64,000 Mr human islet cell antigen in sera from insulin-dependent diabetes mellitus patients and individuals with abnormal glucose tolerance. Mol Biol Med 3 (1986) 137-142
11. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14 (1965) 619-633
12. Tuomilehto J., Zimmet P., Mackay I.R., Koskela P., Vidgren G., Toivanen L., et al. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. [see comment]. Lancet 343 (1994) 1383-1385
13. Schlosser M., Banga J.P., Madec A.M., Binder K.A., Strebelow M., Rjasanowski I., et al. Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes. Diabetologia 48 (2005) 922-930
14. Lernmark A. Glutamic acid decarboxylase-gene to antigen to disease. J Intern Med 240 (1996) 259-277
15. Schwartz H.L., Chandonia J.M., Kash S.F., Kanaani J., Tunnell E., Domingo A., et al. High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase. J Mol Biol 287 (1999) 983-999
16. Syren K., Lindsay L., Stoehrer B., Jury K., Luhder F., Baekkeskov S., et al. Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase. J Immunol 157 (1996) 5208-5214
17. Madec A.M., Rousset F., Ho S., Robert F., Thivolet C., Orgiazzi J., et al. Four IgG anti-islet human monoclonal antibodies isolated from a type 1 diabetes patient recognize distinct epitopes of glutamic acid decarboxylase 65 and are somatically mutated. J Immunol 156 (1996) 3541-3549
18. Tremble J., Morgenthaler N.G., Vlug A., Powers A.C., Christie M.R., Scherbaum W.A., et al. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes. J Clin Endocrinol Metab 82 (1997) 2664-2670
19. Richter W., Endl J., Eiermann T.H., Brandt M., Kientsch-Engel R., Thivolet C., et al. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen. Proc Natl Acad Sci U S A 89 (1992) 8467-8471
20. Syren K., Lindsay L., Stoehrer B., Jury K., Luhder F., Baekkeskov S., et al. Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase. J Immunol (Baltimore, Md) 157 (1996) 5208-5214
21. Fenalti G., Hampe C.S., Arafat Y., Law R.H., Banga J.P., Mackay I.R., et al. COOH-terminal clustering of autoantibody and T-cell determinants on the structure of GAD65 provide insights into the molecular basis of autoreactivity. Diabetes 57 (2008) 1293-1301
22. Estienne V., Duthoit C., Blanchin S., Montserret R., Durand-Gorde J.M., Chartier M., et al. Analysis of a conformational B cell epitope of human thyroid peroxidase: identification of a tyrosine residue at a strategic location for immunodominance. Int Immunol 14 (2002) 359-366
23. Nair D.T., Singh K., Siddiqui Z., Nayak B.P., Rao K.V., and Salunke D.M. Epitope recognition by diverse antibodies suggests conformational convergence in an antibody response. J Immunol 168 (2002) 2371-2382
24. Paus D., and Winter G. Mapping epitopes and antigenicity by site-directed masking. Proc Natl Acad Sci U S A 103 (2006) 9172-9177
25. Plotz P.H. The autoantibody repertoire: searching for order. Nat Rev Immunol 3 (2003) 73-78
26. Tainer J.A., Getzoff E.D., Paterson Y., Olson A.J., and Lerner R.A. The atomic mobility component of protein antigenicity. Annu Rev Immunol 3 (1985) 501-535
27. Thornton J.M., Edwards M.S., Taylor W.R., and Barlow D.J. Location of 'continuous' antigenic determinants in the protruding regions of proteins. EMBO J 5 (1986) 409-413
28. Richter W., Shi Y., and Baekkeskov S. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc Natl Acad Sci U S A 90 (1993) 2832-2836
29. Kohno Y., Hiyama Y., Shimojo N., Niimi H., Nakajima H., and Hosoya T. Autoantibodies to thyroid peroxidase in patients with chronic thyroiditis: effect of antibody binding on enzyme activities. Clin Exp Immunol 65 (1986) 534-541
30. Manns M., Zanger U., Gerken G., Sullivan K.F., Meyer zum Buschenfelde K.H., Meyer U.A., et al. Patients with type II autoimmune hepatitis express functionally intact cytochrome P-450 db1 that is inhibited by LKM-1 autoantibodies in vitro but not in vivo. Hepatology 12 (1990) 127-132
31. Rowley M.J., McNeilage L.J., Armstrong J.M., and Mackay I.R. Inhibitory autoantibody to a conformational epitope of the pyruvate dehydrogenase complex, the major autoantigen in primary biliary cirrhosis. Clin Immunol Immunopathol 60 (1991) 356-370
32. Van de Water J., Fregeau D., Davis P., Ansari A., Danner D., Leung P., et al. Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function. J Immunol 141 (1988) 2321-2324
33. Raju R., Foote J., Banga J.P., Hall T.R., Padoa C.J., Dalakas M.C., et al. Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients. J Immunol 175 (2005) 7755-7762
34. Henzler-Wildman K.A., Lei M., Thai V., Kerns S.J., Karplus M., and Kern D. A hierarchy of timescales in protein dynamics is linked to enzyme catalysis. Nature 450 (2007) 913-916
35. Eisenmesser E.Z., Millet O., Labeikovsky W., Korzhnev D.M., Wolf-Watz M., Bosco D.A., et al. Intrinsic dynamics of an enzyme underlies catalysis. Nature 438 (2005) 117-121
36. Tomatis P.E., Fabiane S.M., Simona F., Carloni P., Sutton B.J., and Vila A.J. Adaptive protein evolution grants organismal fitness by improving catalysis and flexibility. Proc Natl Acad Sci U S A 105 (2008) 20605-20610
37. Breithaupt C., Schubart A., Zander H., Skerra A., Huber R., Linington C., et al. Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein. Proc Natl Acad Sci U S A 100 (2003) 9446-9451
38. Corper A.L., Sohi M.K., Bonagura V.R., Steinitz M., Jefferis R., Feinstein A., et al. Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction. Nat Struct Biol 4 (1997) 374-381
39. Powers A.C., Bavik K., Tremble J., Daw K., Scherbaum W.A., and Banga J.P. Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders. Clin Exp Immunol 118 (1999) 349-356